Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson's disease.
A 63 year old man with a six year history of Parkinson's disease presented with signs of right heart failure following a knee replacement. Constrictive pericarditis was diagnosed and a radical pericardectomy performed. Six months later, the patient remained unwell with raised inflammatory markers. An inflammatory fibrotic reaction caused by cabergoline was diagnosed. He improved after cessation of cabergoline.
Townsend
M
M
Department of Cardiology, Taunton and Somerset Hospital, Musgrove Park, Taunton TA1 5DA, UK. mandietownsend@yahoo.co.uk
MacIver
D H
DH
D000978:Antiparkinson Agents / Q000009:adverse effects*; D000077465:Cabergoline; D004873:Ergolines / Q000009:adverse effects*; D005355:Fibrosis / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010494:Pericarditis, Constrictive / Q000139:chemically induced*; D010994:Pleura / Q000473:pathology*; D011658:Pulmonary Fibrosis / Q000139:chemically induced*
D000978:Antiparkinson Agents; D004873:Ergolines; D000077465:Cabergoline